PCRX

PACIRA BIOSCIENCES INC

Data as of 2026 Q2 (06-30) · 13F snapshot

Summary

PACIRA BIOSCIENCES INC (PCRX) is held as common stock by 4 tracked hedge-fund managers, with a combined reported value of ~$54.78M; the largest are Renaissance Technologies, Izzy Englander, Ken Griffin. This quarter: 1 added, 3 trimmed. 11 public STOCK Act / OGE trade disclosures are on record. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.

Attention · MediumThis quarter · Cooling

Common-stock holders4

Congress trades11

Price$25.65vs quarter-end+1.10%

Sectors0

This quarter's moves

New0

Added1

Trimmed / sold3

Top holder

Renaissance Technologies

Common-stock positions

PUT and CALL disclosures are excluded from these holder counts and values.

Investor	Period	Value	Shares	% of portfolio	Action

Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.